Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Oxygen is essential to life. The respiratory system works tirelessly to provide fresh oxygen to the body and ensure that all metabolic activities can occur unhindered. The respiratory system is what ...

Patients with acute COPD exacerbation should be treated with systemic corticosteroids, antibiotics and NPPV. Systemic corticosteroids reduce treatment failures in both in-hospital and outpatient ...

The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol (hazard ratio, 1.09; 95 percent ...

Background Some patients with COPD ... FE (≥2 exacerbations or 1 hospitalisation due to AECOPD in the previous year) or IE (≤1 exacerbation in the previous year), AECOPD being defined by the ...

This predictive model of acute exacerbation in ... and for intensification of treatment. As a consequence, quality of life and survival rates in patients with COPD would improve.